+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Dry Eye Medication Global Market Opportunities and Strategies to 2030: COVID-19 Impact and Recovery

  • ID: 5353053
  • Report
  • June 2021
  • Region: Global
  • The Business Research Company

FEATURED COMPANIES

  • Adcock Ingram
  • Biolab Pharma
  • Eyepoint pharmaceuticals
  • Johnson & Johnson
  • Novamedika
  • Similasan
  • MORE
Dry Eye Medication Global Market Opportunities and Strategies to 2030: COVID-19 Impact and Recovery provides the strategists, marketers and senior management with the critical information they need to assess the global dry eye medication market as it emerges from the COVID-19 shut down.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Description:

Where is the largest and fastest growing market for the dry eye medication? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The dry eye medication market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider dry eye medication market, and compares it with other markets.

The report covers the following chapters:
  • Executive Summary - The executive summary section of the report gives a brief overview and summary of the report
  • Report Structure - This section gives the structure of the report and the information covered in the various sections.
  • Introduction - The introduction section of the report gives brief introduction about segmentation by geography, segmentation by prescription type, drug variation, type of product, distribution channel and delivery system.
  • Market Characteristics - The market characteristics section of the report defines and explains the dry eye medication market. This chapter includes different goods covered in the report and basic definitions.
  • Product Analysis - The product analysis section of the report describes the leading products in the market along with key features and differentiators for those products.
  • Supply Chain - The supply chain section of the report defines and explains the key players in the dry eye medication industry supply chain.
  • Customer Information - This chapter covers recent customers’ trends/preferences in the global dry eye medication market.
  • Trends and Strategies - This chapter describes the major trends shaping the global dry eye medication market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.
  • Impact of COVID-19 - This section describes the impact of COVID-19 on the dry eye medication market.
  • Unmet Needs In Dry Eye Medication Market - This section describes unmet needs in dry eye medication market.
  • Dry Eye Medication Market, Pricing Analysis - This section provides an overview of the prices charged by the pharmaceutical companies (along with distribution costs) by prescription drugs and over the counter drugs.
  • Overview On Dry Eye Disease, Symptoms, and Line of Treatment Options - This section describes the dry eye disease, symptoms and treatment options.
  • Global Market Size and Growth - This section contains the global historic (2015-2020) and forecast (2020-2025), and (2025-2030) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional Analysis - This section contains the historic (2015-2020) and forecast (2020-2025), and (2025-2030) market values and growth and market share comparison by region.
  • Segmentation - This section contains the market values (2015-2030) and analysis for different segments.
  • Regional Market Size and Growth - This section contains the region’s market size (2020), historic (2015-2020) and forecast (2020-2025), and (2025-2030) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region. The market overview sections of the report describe the current size of the market, background information, government initiatives, regulations, regulatory bodies, associations, corporate tax structure, investments, and major companies.
  • Competitive Landscape - This section covers details on the competitive landscape of the global dry eye medication market, estimated market shares and company profiles of the leading players.
Dry Eye Medication Market, Product Pipeline Analysis The product pipeline analysis section of the report describes top companies’ medication products in pipeline.
  • Key Mergers and Acquisitions - This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
Market Background - This section describes the ophthalmology drugs market of which the dry eye medication market is a segment. This chapter includes the global ophthalmology drugs market 2015-19 and 2019-23 values, and regional and country analyses for the ophthalmology drugs market.
  • Market Opportunities and Strategies - This section includes market opportunities and strategies based on findings of the research. This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.
  • Conclusions and Recommendations - This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for dry eye medication providers in terms of product/service offerings, geographic expansion, marketing strategies and target groups.
  • Appendix - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Scope

Markets Covered:

1) By Prescription Type: OTC Drugs; Prescription Drugs
2) By Drug Variation: Branded Drugs; Generic Drugs
3) By Type of Product: Aqueous; Evaporative; Aqueous and Evaporative
4) By Type of Distribution Channel: Hospital Pharmacies; Eye Health Clinics; Retail Pharmacies; Online Pharmacies
5) By Delivery System: Liquid Drops; Gel; Eye Ointment; Others

Companies Mentioned: Allergan plc; Alcon Inc.; Bausch Health Companies Inc.; Novartis AG; Otsuka Holdings Co, Ltd.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; United States

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, dry eye medication indicators comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Adcock Ingram
  • Biolab Pharma
  • Eyepoint pharmaceuticals
  • Johnson & Johnson
  • Novamedika
  • Similasan
  • MORE
1. Dry Eye Medication Market Executive Summary

2. Table of Contents

3. List of Figures

4. List of Tables

5. Report Structure

6. Introduction
6.1. Segmentation By Geography
6.2. Segmentation By Prescription Type
6.3. Segmentation By Drug Variation
6.4. Segmentation By Type Of Product
6.5. Segmentation By Distribution Channel
6.6. Segmentation By Delivery System

7. Dry Eye Medication Market Characteristics
7.1. Market Definition
7.2. Market Segmentation By Prescription Type
7.2.1. OTC Drugs
7.2.2. Prescription Drugs
7.3. Market Segmentation By Drug Variation
7.3.1. Branded
7.3.2. Generic
7.4. Market Segmentation By Type Of Product
7.4.1. Aqueous
7.4.2. Evaporative
7.4.3. Aqueous and Evaporative
7.5. Market Segmentation By Distribution Channel
7.5.1. Hospital Pharmacies
7.5.2. Eye Health Clinics
7.5.3. Retail Pharmacies
7.5.4. Online Pharmacies
7.6. Market Segmentation By Delivery System
7.6.1. Liquid
7.6.2. Gel
7.6.3. Ointment
7.6.4. Others

8. Dry Eye Medication Market Supply Chain Analysis
8.1. Raw Material Suppliers
8.2. Contract Research Organization (CRO)
8.3. Dry Eye Drugs Manufacturer
8.3.1. Drug Discovery
8.3.2. Preclinical and Clinical Trials
8.3.3. Patents Upon Discovery and Approval
8.3.4. Drug Manufacturing
8.4. Contract Manufacturing Organization (CMO)
8.5. Wholesalers/Distributors
8.6. Retailers (Pharmacies) and Hospitals
8.7. Ophthalmologists and Optometrists
8.8. End-Users

9. Dry Eye Medication Market Product Analysis - Product Examples

10. PVA TEARS™
10.1.1. Santen Pharmaceutical Co., Ltd
10.1.2. Sun Pharmaceuticals Industries, Ltd.

11. Dry Eye Medication Market Customer Information
11.1. Dry Eye Conditions Among Contact Lens Users and Non-Lens Users
11.2. Loss Of Vision Is The Major Concern For Glaucoma Patients
11.3. Majority Of The Patients Do not Seek Preventive Eye Care
11.4. Impact Of Dry Eye Disease (DED) On Patients’ Quality Of Life
11.5. Two-thirds Of Americans Suffer From Eye Problems

12. Dry Eye Medication Market Trends and Strategies
12.1. Single Dose Preservative Free Eye Drops
12.2. Development Of New Mode Of Delivery Systems
12.3. New Product Development
12.4. Rising Research and Collaborations
12.5. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) For Dry Eye Treatment
12.6. Development Of Combination Therapies
12.7. Global Expansion and Acquisitions
12.8. Incorporation of modern techniques
12.9. Nasal Spray therapeutics for treating dry eye

13. Impact Of COVID-19 On The Dry Eye Medication Market
13.1. Consumer Perception
13.2. Occurrence Of Conjunctivitis In COVID-19 Patients
13.3. Drugs Used In COVID-19 Patients Are Likely To Develop Eye Risks
13.4. Effect Of Screens
13.5. Severe Eye Abnormalities

14. Unmet Needs In Dry Eye Medication Market
14.1. Diagnostic Challenges Leading to Improper Treatment Decisions
14.2. Low Insurance Coverage For Dry Eye Medications
14.3. Variations In The Availability Of Dry Eye Drugs Across Countries
14.4. Poor Compliance and High Rates Of Discontinuation Of Dry Eye Drugs

15. Dry Eye Medication Market, Pricing Analysis
15.1. Pricing Analysis Of Prescription Drugs
15.2. Pricing Analysis Of Over The Counter Drugs

16. Overview On Dry Eye Disease, Symptoms, and Line Of Treatment Options
16.1. Dry Eye Disease Overview
16.2. Causes and Symptoms of Dry Eyes
16.3. Treatment Options For Dry Eye Disease
16.3.1. Mild Dry Eye Symptoms
16.3.2. Moderate Dry Eye Symptoms
16.3.3. Moderate To Severe Dry Eye Symptoms

17. Global Dry Eye Medication Market Size and Growth
17.1. Market Size
17.2. Historic Market Growth, 2015 - 2020, Value ($ Million)
17.2.1. Drivers Of The Market 2015 - 2020
17.2.2. Restraints On The Market 2015 - 2020
17.3. Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
17.3.1. Drivers Of The Market 2020 - 2025
17.3.2. Restraints On The Market 2020 - 2025

18. Dry Eye Medication Market, Regional and Country Analysis
18.1. Global Dry Eye Medication Market, By Region, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
18.2. Global Dry Eye Medication Market, 2015 - 2025, Historic and Forecast, By Region
18.3. Global Dry Eye Medication Market, 2020 - 2025, Growth and Market Share Comparison, By Region
18.4. Global Dry Eye Medication Market, By Country, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

19. Global Dry Eye Medication Market Segmentation
19.1. Global Dry Eye Medication Market, Segmentation By Delivery System, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
19.1.1. Liquid Drops
19.1.2. Gel
19.1.3. Others
19.1.4. Eye Ointment
19.2. Global Dry Eye Medication Market, Segmentation By Distribution Channel, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
19.2.1. Retail Pharmacies
19.2.2. Hospital Pharmacies
19.2.3. Eye Health Clinics
19.2.4. Online Pharmacies
19.3. Global Dry Eye Medication Market, Segmentation By Type Of Product, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
19.3.1. Aqueous and Evaporative
19.3.2. Aqueous
19.3.3. Evaporative
19.4. Global Dry Eye Medication Market, Segmentation By Prescription Type, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
19.4.1. OTC Drugs
19.4.2. Prescription Drugs
19.5. Global Dry Eye Medication Market, Segmentation By Drug Variation, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
19.5.1. Branded Drugs
19.5.2. Generic Drugs

20. Global Dry Eye Medication Market Comparison with Macro Economic Factors
20.1. Dry Eye Medication Market Size, Percentage Of GDP, Global
20.2. Per Capita Average Dry Eye Medication Market Expenditure, Global

21. Asia-Pacific Dry Eye Medication Market
21.1. Asia-Pacific Dry Eye Medication Market Overview
21.1.1. Region Information
21.1.2. Market Information
21.1.3. Impact of COVID-19
21.1.4. Background Information
21.1.5. New Drug Approval
21.1.6. Government Initiatives
21.1.7. Regulations
21.1.8. Regulatory Bodies
21.1.9. Major Associations
21.1.10. Corporate Tax Structure
21.1.11. Tax Levied
21.1.12. Investments
21.1.13. Major Companies
21.2. Asia-Pacific Dry Eye Medication Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
21.3. Asia-Pacific Dry Eye Medication Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
21.4. Asia-Pacific Dry Eye Medication Market, Segmentation By Delivery System, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
21.5. Asia-Pacific Dry Eye Medication Market, Segmentation By Distribution Channel, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
21.6. Asia-Pacific Dry Eye Medication Market, Segmentation By Type Of Product, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
21.7. Asia-Pacific Dry Eye Medication Market: Country Analysis
21.8. China Dry Eye Medication Market
21.9. China Dry Eye Medication Market Overview
21.9.1. Country Information
21.9.2. Market Information
21.9.3. Impact of COVID-19
21.9.4. Background Information
21.9.5. New Drug Approval
21.9.6. Government Initiatives
21.9.7. Regulations
21.9.8. Regulatory Bodies
21.9.9. Major Associations
21.9.10. Tax Levied
21.9.11. Corporate Tax Structure
21.9.12. Investments
21.9.13. Major Companies
21.10. China Dry Eye Medication Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
21.11. China Dry Eye Medication Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
21.12. China Dry Eye Medication Market, Segmentation By Delivery System, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
21.13. China Dry Eye Medication Market, Segmentation By Distribution Channel, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
21.14. China Dry Eye Medication Market, Segmentation By Type Of Product, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
21.15. India Dry Eye Medication Market
21.16. India Dry Eye Medication Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
21.17. India Dry Eye Medication Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
21.18. India Dry Eye Medication Market, Segmentation By Delivery System, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
21.19. India Dry Eye Medication Market, Segmentation By Distribution Channel, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
21.20. India Dry Eye Medication Market, Segmentation By Type Of Product, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
21.21. Japan Dry Eye Medication Market
21.22. Japan Dry Eye Medication Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
21.23. Japan Dry Eye Medication Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
21.24. Japan Dry Eye Medication Market, Segmentation By Delivery System, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
21.25. Japan Dry Eye Medication Market, Segmentation By Distribution Channel, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
21.26. Japan Dry Eye Medication Market, Segmentation By Type Of Product, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
21.27. Australia Dry Eye Medication Market
21.28. Australia Dry Eye Medication Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
21.29. Australia Dry Eye Medication Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
21.30. Australia Dry Eye Medication Market, Segmentation By Delivery System, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
21.31. Australia Dry Eye Medication Market, Segmentation By Distribution Channel, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
21.32. Australia Dry Eye Medication Market, Segmentation By Type Of Product, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
21.33. Indonesia Dry Eye Medication Market
21.34. Indonesia Dry Eye Medication Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
21.35. Indonesia Dry Eye Medication Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
21.36. Indonesia Dry Eye Medication Market, Segmentation By Delivery System, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
21.37. Indonesia Dry Eye Medication Market, Segmentation By Distribution Channel, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
21.38. Indonesia Dry Eye Medication Market, Segmentation By Type Of Product, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
21.39. South Korea Dry Eye Medication Market
21.40. South Korea Dry Eye Medication Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
21.41. South Korea Dry Eye Medication Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
21.42. South Korea Dry Eye Medication Market, Segmentation By Delivery System, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
21.43. South Korea Dry Eye Medication Market, Segmentation By Distribution Channel, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
21.44. South Korea Dry Eye Medication Market, Segmentation By Type Of Product, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

22. Western Europe Dry Eye Medication Market
22.1. Western Europe Dry Eye Medication Market Overview
22.1.1. Region Information
22.1.2. Market Information
22.1.3. Impact of COVID-19
22.1.4. Background Information
22.1.5. Government Initiatives
22.1.6. Regulations
22.1.7. Regulatory Bodies
22.1.8. Major Associations
22.1.9. Taxes Levied
22.1.10. Corporate Tax Structure
22.1.11. Investments
22.1.12. Major Companies
22.2. Western Europe Dry Eye Medication Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
22.3. Western Europe Dry Eye Medication Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
22.4. Western Europe Dry Eye Medication Market, Segmentation By Delivery System, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
22.5. Western Europe Dry Eye Medication Market, Segmentation By Distribution Channel, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
22.6. Western Europe Dry Eye Medication Market, Segmentation By Type Of Product, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
22.7. Western Europe Dry Eye Medication Market: Country Analysis
22.8. UK Dry Eye Medication Market
22.9. UK Dry Eye Medication Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
22.10. UK Dry Eye Medication Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
22.11. UK Dry Eye Medication Market, Segmentation By Delivery System, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
22.12. UK Dry Eye Medication Market, Segmentation By Distribution Channel, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
22.13. UK Dry Eye Medication Market, Segmentation By Type Of Product, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
22.14. Germany Dry Eye Medication Market
22.15. Germany Dry Eye Medication Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
22.16. Germany Dry Eye Medication Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
22.17. Germany Dry Eye Medication Market, Segmentation By Delivery System, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
22.18. Germany Dry Eye Medication Market, Segmentation By Distribution Channel, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
22.19. Germany Dry Eye Medication Market, Segmentation By Type Of Product, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
22.20. France Dry Eye Medication Market
22.21. France Dry Eye Medication Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
22.22. France Dry Eye Medication Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
22.23. France Dry Eye Medication Market, Segmentation By Delivery System, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
22.24. France Dry Eye Medication Market, Segmentation By Distribution Channel, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
22.25. France Dry Eye Medication Market, Segmentation By Type Of Product, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
22.26. Spain Dry Eye Medication Market
22.27. Spain Dry Eye Medication Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
22.28. Spain Dry Eye Medication Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
22.29. Spain Dry Eye Medication Market, Segmentation By Delivery System, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
22.30. Spain Dry Eye Medication Market, Segmentation By Distribution Channel, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
22.31. Spain Dry Eye Medication Market, Segmentation By Type Of Product, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
22.32. Italy Dry Eye Medication Market
22.33. Italy Dry Eye Medication Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
22.34. Italy Dry Eye Medication Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
22.35. Italy Dry Eye Medication Market, Segmentation By Delivery System, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
22.36. Italy Dry Eye Medication Market, Segmentation By Distribution Channel, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
22.37. Italy Dry Eye Medication Market, Segmentation By Type Of Product, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

23. Eastern Europe Dry Eye Medication Market
23.1. Eastern Europe Dry Eye Medication Market Overview
23.1.1. Region Information
23.1.2. Market Information
23.1.3. Impact of COVID-19
23.1.4. Background Information
23.1.5. New Drug Approvals
23.1.6. Government Initiatives
23.1.7. Regulations
23.1.8. Regulatory Bodies
23.1.9. Major Associations
23.1.10. Taxes Levied
23.1.11. Corporate Tax Structure
23.1.12. Investments
23.1.13. Major Companies
23.2. Eastern Europe Dry Eye Medication Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
23.3. Eastern Europe Dry Eye Medication Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
23.4. Eastern Europe Dry Eye Medication Market, Segmentation By Delivery System, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
23.5. Eastern Europe Dry Eye Medication Market, Segmentation By Distribution Channel, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
23.6. Eastern Europe Dry Eye Medication Market, Segmentation By Type Of Product, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
23.7. Eastern Europe Dry Eye Medication Market: Country Analysis
23.8. Russia Dry Eye Medication Market
23.9. Russia Dry Eye Medication Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
23.10. Russia Dry Eye Medication Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
23.11. Russia Dry Eye Medication Market, Segmentation By Delivery System, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
23.12. Russia Dry Eye Medication Market, Segmentation By Distribution Channel, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
23.13. Russia Dry Eye Medication Market, Segmentation By Type Of Product, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

24. North America Dry Eye Medication Market
24.1. North America Dry Eye Medication Market Overview
24.1.1. Region Information
24.1.2. Market Information
24.1.3. Impact of COVID-19
24.1.4. Background Information
24.1.5. Government Initiatives
24.1.6. Regulations
24.1.7. Regulatory Bodies
24.1.8. Major Associations
24.1.9. Tax Levied
24.1.10. Corporate Tax Structure
24.1.11. Investments
24.1.12. Major Companies
24.2. North America Dry Eye Medication Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
24.3. North America Dry Eye Medication Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
24.4. North America Dry Eye Medication Market, Segmentation By Delivery System, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
24.5. North America Dry Eye Medication Market, Segmentation By Distribution Channel, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
24.6. North America Dry Eye Medication Market, Segmentation By Type Of Product, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
24.7. North America Dry Eye Medication Market: Country Analysis
24.8. USA Dry Eye Medication Market
24.9. USA Dry Eye Medication Market Overview
24.9.1. Country Information
24.9.2. Market Information
24.9.3. Impact of COVID-19
24.9.4. Background Information
24.9.5. Government Initiatives
24.9.6. Regulations
24.9.7. Regulatory Bodies
24.9.8. Major Associations
24.9.9. Tax Levied
24.9.10. Corporate Tax Structure
24.9.11. Investments
24.9.12. Major Companies
24.10. USA Dry Eye Medication Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
24.11. USA Dry Eye Medication Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
24.12. USA Dry Eye Medication Market, Segmentation By Delivery System, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
24.13. USA Dry Eye Medication Market, Segmentation By Distribution Channel, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
24.14. USA Dry Eye Medication Market, Segmentation By Type Of Product, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

25. South America Dry Eye Medication Market
25.1. South America Dry Eye Medication Market Overview
25.1.1. Region Information
25.1.2. Market Information
25.1.3. Impact of COVID-19
25.1.4. Background Information
25.1.5. Government Initiatives
25.1.6. Regulations
25.1.7. Regulatory Bodies
25.1.8. Major Associations
25.1.9. Tax Levied
25.1.10. Corporate Tax Structure
25.1.11. Investments
25.1.12. Major Companies
25.2. South America Dry Eye Medication Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
25.3. South America Dry Eye Medication Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
25.4. South America Dry Eye Medication Market, Segmentation By Delivery System, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
25.5. South America Dry Eye Medication Market, Segmentation By Distribution Channel, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
25.6. South America Dry Eye Medication Market, Segmentation By Type Of Product, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
25.7. South America Dry Eye Medication Market: Country Analysis
25.8. Brazil Dry Eye Medication Market
25.9. Brazil Dry Eye Medication Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
25.10. Brazil Dry Eye Medication Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
25.11. Brazil Dry Eye Medication Market, Segmentation By Delivery System, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
25.12. Brazil Dry Eye Medication Market, Segmentation By Distribution Channel, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
25.13. Brazil Dry Eye Medication Market, Segmentation By Type Of Product, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

26. Middle East Dry Eye Medication Market
26.1. Middle East Dry Eye Medication Market Overview
26.1.1. Region Information
26.1.2. COVID-19 Impact
26.1.3. Market Information
26.1.4. Background Information
26.1.5. New Drug Approvals
26.1.6. Government Initiatives
26.1.7. Regulations
26.1.8. Regulatory Bodies
26.1.9. Major Associations
26.1.10. Taxes Levied
26.1.11. Corporate Tax Structure
26.1.12. Investments
26.1.13. Major Companies
26.2. Middle East Dry Eye Medication Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
26.3. Middle East Dry Eye Medication Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
26.4. Middle East Dry Eye Medication Market, Segmentation By Delivery System, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
26.5. Middle East Dry Eye Medication Market, Segmentation By Distribution Channel, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
26.6. Middle East Dry Eye Medication Market, Segmentation By Type Of Product, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

27. Africa Dry Eye Medication Market
27.1. Africa Dry Eye Medication Market Overview
27.1.1. Region Information
27.1.2. Market Information
27.1.3. Impact of COVID-19
27.1.4. Background Information
27.1.5. Government Initiatives
27.1.6. Regulations
27.1.7. Regulatory Bodies
27.1.8. Major Associations
27.1.9. Taxes Levied
27.1.10. Corporate Tax Structure
27.1.11. Major Companies
27.2. Africa Dry Eye Medication Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
27.3. Africa Dry Eye Medication Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
27.4. Africa Dry Eye Medication Market, Segmentation By Delivery System, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
27.5. Africa Dry Eye Medication Market, Segmentation By Distribution Channel, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
27.6. Africa Dry Eye Medication Market, Segmentation By Type Of Product, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

28. Global Dry Eye Medication Market Competitive Landscape
28.1. Company Profiles
28.2. Allergan Plc.
28.2.1. Company Overview
28.2.2. Products and Services
28.2.3. Business Strategy
28.2.4. Financial Overview
28.3. Alcon Inc.
28.3.1. Company Overview
28.3.2. Products and Services
28.3.3. Business Strategy
28.3.4. Financial Overview
28.4. Bausch Health Companies Inc.
28.4.1. Company Overview
28.4.2. Products and Services
28.4.3. Business Strategy
28.4.4. Financial Overview
28.5. Novartis AG
28.5.1. Company Overview
28.5.2. Products and Services
28.5.3. Business Strategy
28.5.4. Financial Overview
28.6. Otsuka Holdings Co, Ltd.
28.6.1. Company Overview
28.6.2. Products and Services
28.6.3. Business Strategy
28.6.4. Financial Overview

29. Dry Eye Medication Market, Product Pipeline Analysis
29.1.1. Novartis AG
29.1.2. Allergan
29.1.3. Senju Pharmaceuticals

30. Key Mergers and Acquisitions In The Dry Eye Medication Market
30.1. Bausch Health Acquired Global Rights for Risuteganib Of Allegro Ophthalmics
30.2. Aerie Pharmaceuticals Acquired Avizorex Pharma
30.3. Novartis Acquired Xiidra From Takeda Pharmaceutical
30.4. Takeda Pharmaceutical Acquired Shire Plc
30.5. AbbVie Acquired Allergan
30.6. Alcon Acquired Tear Film Innovations, Inc.
30.7. Sun Pharmaceutical Industries Limited Acquired Ocular Technologies S.à r.l.
30.8. Sun Pharmaceutical Industries Limited Acquired InSite Vision Inc.
30.9. Actavis Plc. Acquired Allergan Inc.
31. Market Background: Ophthalmology Drugs Market
31.1. Ophthalmology Drugs Market Characteristics
31.1.1. Market Definition
31.1.2. Market Segmentation By Therapeutic Class
31.1.3. Antiglaucoma Drugs
31.1.4. Dry Eye Medication
31.1.5. Other Ophthalmological Drugs
31.2. Global Ophthalmology Drugs Market, Segmentation By Type, 2015 - 2025, Value ($ Billion)
31.3. Global Ophthalmology Drugs Market, 2020, By Region, Value ($ Billion)
31.4. Global Ophthalmology Drugs Market, 2015 - 2025, Historic and Forecast, By Region
32. Global Dry Eye Medication Market Opportunities and Strategies
32.1. Global Dry Eye Medication Market In 2025 - Countries Offering Most New Opportunities
32.2. Global Dry Eye Medication Market In 2025 - Segments Offering Most New Opportunities
32.3. Global Dry Eye Medication Market In 2025 - Growth Strategies
32.3.1. Market Trend Based Strategies
32.3.2. Competitor Strategies
33. Dry Eye Medication Market, Conclusions and Recommendations
33.1. Conclusions
33.2. Recommendations
33.2.1. Product
33.2.2. Place
33.2.3. Price
33.2.4. Promotion
33.2.5. People
34. Appendix
34.1. Market Data Sources
34.2. Research Methodology
34.3. Currencies
34.4. Research Inquiries
34.5. About the Publisher
34.6. Copyright and Disclaimer
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Adcock Ingram
  • Biolab Pharma
  • Eyepoint pharmaceuticals
  • Johnson & Johnson
  • Novamedika
  • Similasan
  • MORE
This report describes and evaluates the global dry eye medication market. It covers 2015 to 2020, termed the historic period, and 2020 to 2025 termed the forecast period, along with further forecasts for the period 2025 to 2030.

The global dry eye medication market is expected to grow from $2,892.8 million in 2015 to $ 3,245.6 million in 2020 at a compound annual growth rate (CAGR) of 2.3%%. The market is expected to grow at a CAGR of 8.2% to nearly $4,806.0 million by 2025, and at a CAGR of 5.7% to $6,329.7 million by 2030.

Growth in the historic period resulted from an aging population, rising number of contact lens users, increase in disposable income, increase in number of treatment options, increase in number of allergies, rise in consumption of unhealthy or improper diets, and prevalence of diabetes mellitus. Factors that negatively affected growth in the historic period were low healthcare access, and a lack of awareness of the dry eye medication products.

Going forward, rising laser surgeries, rising screen time, busy lifestyles, the increasing burden of diabetes, increase in prevalence of dry eye disease, promising pipeline for dry eye disease, and side effects of other medications will drive growth. Factors that could hinder the growth of the dry eye medication market in the future include long and costly drug approvals, stringent rules and regulations and disruption in the supply chain of drugs related to dry eyes due to the impact of covid-19.

The dry eye medication market is segmented by type of product into aqueous, evaporative and aqueous and evaporative. The aqueous and evaporative market was the largest segment of the dry eye medication market segmented by type of product, accounting for $2,670.9 million or 82.3% of the total in 2020. The evaporative market is expected to be the fastest-growing segment going forward at a CAGR of 8.9% during 2020-2025.

The dry eye medication market is segmented by type of distribution channel into hospital pharmacies, eye health clinics, retail pharmacies and online pharmacies. The retail pharmacies was the largest segment of the dry eye medication market segmented by distribution channel, accounting for $2,063.9 million or 63.6% of the total in 2020. The online pharmacies market is expected to be the fastest-growing segment going forward at a CAGR of 14.3%.

The dry eye medication market is segmented by prescription type into OTC drugs, and prescription drugs. The OTC drugs was the largest segment of the dry eye medication market segmented by prescription type, accounting for $1,723.1 million or 53.1% of the total in 2020. The prescription drugs market is expected to be the fastest-growing segment going forward at a CAGR of 10.1% during 2020-2025.

The dry eye medication market is segmented by drug variation into branded drugs, and generic drugs. The branded drugs segment was the largest segment of the dry eye medication market segmented by drug variation, accounting for $2,070.7 million or 63.8% of the total in 2020. Going forward, the generic drugs is expected to be the fastest-growing segment at a CAGR of 10.3% during 2020-2025.

The dry eye medication market is segmented by delivery system into liquid drops, gel, eye ointment and others. The liquid drops were the largest segment of the dry eye medication market segmented by delivery system, accounting for $3,164.8 million or 97.5% of the total in 2020. The eye ointment market is expected to be the fastest-growing segment going forward at a CAGR of 23.2%. 

North America was the largest region in the dry eye medication market, accounting for 31.3% of the global market in 2020. It was followed by Asia Pacific, Western Europe, and then the other regions. Going forward, the fastest growing regions in the dry eye medication market will be the Middle East and Africa, where growth will be at CAGRs of 20.2% and 12.1% respectively. These will be followed by Western Europe and North America where the markets are expected to grow at CAGRs of 8.3% and 7.6% respectively.

The dry eye medication market is highly concentrated, with a small number of large players. The top ten competitors in the market made up to 78.16% of the total market in 2019. Major players in the market include Allergan plc, Alcon Inc, Bausch Health Companies Inc., Novartis AG, Otsuka Holdings Co, Ltd. and others.

The global ophthalmology drugs market, of which the dry eye medication market is a segment, reached a value of nearly $22.0 billion in 2020, growing at a compound annual growth rate (CAGR) of 2.8% since 2015. It is expected to grow at a CAGR of 8.2% and reach nearly $32.6 billion by 2025.

The other ophthalmology drugs market was the largest segment in the global ophthalmology drugs market accounting for59.1% of the total in 2020 and is expected to grow the fastest at a CAGR of 8.6% during 2020-2025. The dry eye medication market was the smallest segment in the global ophthalmology drugs market, accounting for 14.7% of the total and was valued at $3.2 billion in 2020.

The top opportunities in the dry eye medication market segmented by type will arise in aqueous and evaporative segment, which will gain $1,264.5 million of global annual sales by 2025. The top opportunities in the dry eye medication market segmented by distribution channel will arise in the retail pharmacies segment, which will gain $838.9 million of global annual sales by 2025. The top opportunities in the dry eye medication market segmented by prescription type will arise in the prescription drugs segment, which will gain $943.0 million of global annual sales by 2025. The top opportunities in the dry eye medication market segmented by delivery system will arise in the liquid drops segment, which will gain $1,492.5 million of global annual sales by 2025. The top opportunities in the dry eye medication market segmented by drug variation will arise in the branded drugs segment, which will gain $820.5 million of global annual sales by 2025.

The dry eye medication market size will gain the most in USA at $375.1 million. Market-trend-based strategies for the dry eye medication market include developing develop preservative free eye drops, investing in research and development of new and advanced drugs, developing innovative drugs to survive in the market, developing non-steroidal anti-inflammatory ophthalmic drugs for the treatment of dry-eye syndrome, focusing on incorporating modern techniques, and developing combination therapies for the treatment of dry eye diseases. Player-adopted strategies in the dry eye medication market include expanding through acquisitions, expanding through building diverse dry eye medication portfolio and launching new innovative drugs.

The outbreak of coronavirus has caused a shortage in the supply of essential eye medications for the treatment of dry eyes. This is because the COVID-19 pandemic created disruption in the global pharmaceutical supply chain, which is heavily dependent on China. The main raw materials in the drug production are manufactured in China and are exported to other parts of the world after making the final drug. This has resulted in pharmacies and wholesalers reporting many drugs being out of stock. Owing to the shortage of medications, governments are advising pharmacists to limit the dispensing of certain dry eye prescription medicines such as chloramphenicol (an antibiotic for conjunctivitis) eye drops and ointments to a one-month supply according to the prescribed dose. Also, pharmacists are recommended to sell certain over the counter medicines (OTC) to a maximum of one unit per purchase due the concern on the significant health impacts on the patients that can be caused due to the shortage of medicines during this pandemic.

To take advantage of the opportunities, the publisher recommends the dry eye medication manufacturing companies to focus on development of new mode of delivery systems, focus on incorporating modern techniques, expand in emerging markets, scale up through merger and acquisition activity, offer competitive pricing, conduct eye care seminars and fairs, partner with big brands, target distributors in emerging markets and collaborate with e-commerce companies.
Note: Product cover images may vary from those shown
  • Santen Pharmaceutical Co., Ltd.
  • Sentiss Pharma Pvt. Ltd.
  • OASIS Medical, Inc.
  • VISUfarma B.V.
  • Sun Pharmaceutical Industries Limited
  • Bayer AG
  • Pfizer
  • Johnson & Johnson
  • Daiichi Sankyo
  • ERC Labs
  • Vision gain
  • Medicom Health care
  • Implandata ophthalmic products GmbH
  • The Geuder Group
  • Novamedika
  • Aflofarm Farmacja Polska
  • VUAB Pharma, Inc.
  • Endo International plc
  • Aurinia Pharmaceuticals Inc
  • Herzig Eye Institute
  • Thomas Eye Group
  • Alimera Sciences
  • Eyegate
  • Neurotech
  • Opthotech
  • Eyepoint pharmaceuticals
  • Gama Vision
  • Biolab Pharma
  • Mitotech
  • Novaliq GmbH
  • Horus Pharma
  • Prestige Consumer Healthcare, Inc
  • Azura Ophthamics, Ltd
  • Similasan
  • Hoya Corporation
  • Adcock Ingram
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll